Prelude Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32,308	Closed	-$77K	–	1229
2020 Q3	$77K	Buy	+32,308	New	+$88.6K	0.01%	994
2018 Q4	–	Sell	-47,400	Closed	-$294K	–	1738
2018 Q3	$294K	Sell	47,400 -11,479	-19%	-$66.1K	0.02%	676
2018 Q2	$266K	Buy	58,879 +1,579	+3%	+$7.87K	0.02%	696
2018 Q1	$264K	Buy	57,300 +14,924	+35%	+$59.3K	0.02%	616
2017 Q4	$136K	Buy	42,376 +3,376	+9%	+$9.44K	0.01%	708
2017 Q3	$120K	Buy	39,000 +3,853	+11%	+$12.8K	0.01%	824
2017 Q2	$130K	Buy	35,147 +2,451	+7%	+$9.84K	0.01%	707
2017 Q1	$160K	Buy	32,696 +2,696	+9%	+$13.3K	0.02%	635
2016 Q4	$154K	Buy	30,000 +3,671	+14%	+$21.1K	0.02%	674
2016 Q3	$191K	Buy	26,329 +8,229	+45%	+$52.2K	0.03%	582
2016 Q2	$108K	Buy	18,100 +4,905	+37%	+$34.4K	0.02%	724
2016 Q1	$107K	Buy	13,195 +1,195	+10%	+$6.83K	0.02%	745
2015 Q4	$97K	Buy	12,000 +1,000	+9%	+$9K	0.02%	822
2015 Q3	$92K	Buy	11,000 +2,600	+31%	+$24K	0.02%	864
2015 Q2	$78K	Buy	8,400 +7,400	+740%	+$64K	0.01%	980
2015 Q1	$10K	Sell	1,000 -600	-38%	-$6.05K	﹤0.01%	1828
2014 Q4	$18K	Buy	+1,600	New	+$18.3K	﹤0.01%	1752